Kirill Gorshkov, PhD
About Kirill Gorshkov, PhD
Kirill Gorshkov, PhD, is a Principal Scientist at Bristol Myers Squibb in Princeton, New Jersey, with extensive experience in high-content imaging, high-throughput screening, and pre-clinical drug development for rare diseases. He has co-authored 31 peer-reviewed articles and has a strong background in molecular pharmacology and neurobiology.
Current Role at Bristol Myers Squibb
Kirill Gorshkov, PhD, currently serves as a Principal Scientist at Bristol Myers Squibb in Princeton, New Jersey, United States. His expertise includes high-content imaging and high-throughput screening, which are pivotal in pre-clinical drug development. He leverages his extensive background in lab automation and drug discovery to advance research in rare and neglected diseases.
Tenure at National Center for Advancing Translational Sciences (NCATS)
From 2016 to 2021, Kirill Gorshkov worked at the National Center for Advancing Translational Sciences (NCATS) as a Staff Scientist I in Rockville, Maryland, United States. During this period, he contributed significantly to translational research, emphasizing high-content imaging and high-throughput screening. His work at NCATS focused on bridging the gap between basic research and clinical application.
Education and Academic Achievements
Kirill Gorshkov earned his PhD in Molecular Pharmacology from The Johns Hopkins University School of Medicine in 2016. During his doctoral studies, he developed novel sensors for difficult-to-study kinases and conducted research on the subcellular dynamics of cGMP signaling. He also studied Neurobiology and Neurosciences, obtaining a Bachelor of Science degree from The University of Texas at Austin in 2010. His academic research included developing a novel luciferase-based assay for epilepsy drug screens.
Previous Experience in Biotechnology and Pharmaceuticals
Kirill Gorshkov has extensive experience in the biotechnology and pharmaceutical industries. He served as a Research Intern at Eli Lilly and Company in 2015, focusing on GLP-1 agonist discovery research within their Diabetes - Islet Biology division. He also completed internships at the MD Anderson Cancer Center and was involved in undergraduate research at The University of Texas at Austin.
Scientific Contributions and Publications
Kirill Gorshkov has co-authored 31 peer-reviewed scientific articles, achieving an h-index of 22 and an i-index of 25 with a total of 1401 citations. His research contributions span multiple areas, including the discovery of a protein-protein interaction inhibitor that accelerated axon outgrowth in rat hippocampal neurons. His work has earned recognition in the scientific community, contributing to advancements in drug discovery and neurobiology.